FDx Advisors Inc. lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 36.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,555 shares of the company’s stock after selling 3,716 shares during the period. FDx Advisors Inc.’s holdings in Henry Schein were worth $476,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. American Century Companies Inc. grew its holdings in shares of Henry Schein by 21.2% during the 2nd quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock valued at $159,202,000 after acquiring an additional 383,479 shares in the last quarter. Schwab Charles Investment Management Inc. grew its holdings in shares of Henry Schein by 3.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 629,646 shares of the company’s stock valued at $45,738,000 after acquiring an additional 20,185 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Henry Schein by 15.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 88,354 shares of the company’s stock valued at $6,419,000 after acquiring an additional 11,912 shares in the last quarter. Canada Pension Plan Investment Board grew its holdings in shares of Henry Schein by 2,487.4% during the 2nd quarter. Canada Pension Plan Investment Board now owns 127,844 shares of the company’s stock valued at $9,287,000 after acquiring an additional 122,903 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in shares of Henry Schein by 57.1% during the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after acquiring an additional 800 shares in the last quarter. 96.65% of the stock is currently owned by institutional investors.

Several equities analysts have recently commented on HSIC shares. Craig Hallum boosted their price target on shares of Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 price objective for the company in a research note on Tuesday, July 10th. TheStreet raised shares of Henry Schein from a “c” rating to a “b-” rating in a research note on Monday, May 14th. BidaskClub lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Friday, August 10th. Finally, Leerink Swann set a $100.00 price objective on shares of Henry Schein and gave the company a “buy” rating in a research note on Tuesday, August 7th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $84.11.

Henry Schein stock opened at $77.00 on Friday. The firm has a market cap of $12.43 billion, a price-to-earnings ratio of 21.39, a PEG ratio of 2.32 and a beta of 1.00. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.29 and a quick ratio of 0.68. Henry Schein, Inc. has a fifty-two week low of $62.56 and a fifty-two week high of $89.34.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, August 6th. The company reported $1.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.03. The firm had revenue of $3.33 billion during the quarter, compared to analyst estimates of $3.31 billion. Henry Schein had a net margin of 3.15% and a return on equity of 20.40%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.88 EPS. equities analysts forecast that Henry Schein, Inc. will post 4.11 earnings per share for the current fiscal year.

In other Henry Schein news, Director Paul Brons sold 4,822 shares of the business’s stock in a transaction on Monday, June 11th. The shares were sold at an average price of $72.93, for a total transaction of $351,668.46. Following the completion of the transaction, the director now owns 20,889 shares of the company’s stock, valued at approximately $1,523,434.77. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Mark E. Mlotek sold 10,359 shares of the business’s stock in a transaction on Tuesday, June 12th. The stock was sold at an average price of $72.73, for a total transaction of $753,410.07. Following the transaction, the executive vice president now directly owns 79,506 shares of the company’s stock, valued at approximately $5,782,471.38. The disclosure for this sale can be found here. 1.15% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Article: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.